Anthony Weinstock, DO
Weinstock is a second-year internal medicine resident based in southwestern Virginia and has been a member of the Infectious Diseases Society of America since his second year of medical school. He is passionate about antimicrobial discovery and medical education.
Articles
Rifaquizinone: A Novel Rifamycin-Quinolone Hybrid Antibiotic
April 28th 2025Rifaquizinone is a dual-pharmacophore antibiotic combining rifamycin and a fluoroquinolone-like compound, showing strong bactericidal activity against resistant Staphylococcus aureus strains and biofilms, with promising results for treating prosthetic joint infections (PJI) but limited oral bioavailability.
Read More
Latest Updated Articles
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: April 25th 2025 | Updated: April 29th 2025
FDA Requests Additional Trial of Novavax NVX-CoV2601 Vaccine Prior to Approval
Published: April 23rd 2025 | Updated: April 29th 2025
Next-Generation Antivirals Outperform Paxlovid in Preclinical Coronavirus Testing
Published: April 21st 2025 | Updated: April 29th 2025
The Impact of the Pandemic on Antimicrobial Resistance
Published: April 23rd 2025 | Updated: April 23rd 2025
CDC Reports 800 Confirmed Measles Cases Across the US, 624 Being in Texas
Published: April 23rd 2025 | Updated: April 29th 2025
Working to Prevent Malaria Through Genomic Research, Education
